Literature DB >> 16461217

New targets and inhibitors of HBV replication to combat drug resistance.

Yung-Chi Cheng1, Chun-Xiao Ying, Chung-Hang Leung, Ying Li.   

Abstract

All the approved chemotherapeutic drugs for the treatment of HBV hepatitis are nucleoside analogs targeting on HBV DNA polymerase. Drugs targeting on other viral unique targets are needed. A new class of chemicals with novel action against HBV replication was discovered. A brief description of their mode of action is given.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16461217     DOI： 10.1016/s1386-6532(05)80026-5

Source DB:  PubMed          Journal:  J Clin Virol        ISSN： 1386-6532            Impact factor:   3.168


  10 in total

Review 1.  Novel approaches towards conquering hepatitis B virus infection.

Authors:  Guo-Yi Wu; Hong-Song Chen
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

2.  Effects of two novel nucleoside analogues on different hepatitis B virus promoters.

Authors:  Xing-Xing He; Ju-Sheng Lin; Ying Chang; Ying-Hui Zhang; Yan Li; Xiao-Yan Wang; Dong Xu; Xiao-Ming Cheng
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

3.  Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue.

Authors:  Chunxiao Ying; Ying Li; Chung-Hang Leung; Michael D Robek; Yung-Chi Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

4.  Antiviral treatment of chronic hepatitis B virus (HBV) infections.

Authors:  Erik De Clercq; Geoffrey Férir; Suzanne Kaptein; Johan Neyts
Journal:  Viruses       Date:  2010-05-31       Impact factor: 5.818

Review 5.  Drugs in Development for Hepatitis B.

Authors:  Altaf Dawood; Syed Abdul Basit; Mahendran Jayaraj; Robert G Gish
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

6.  Design, synthesis, and molecular hybrids of caudatin and cinnamic acids as novel anti-hepatitis B virus agents.

Authors:  Li-Jun Wang; Chang-An Geng; Yun-Bao Ma; Jie Luo; Xiao-Yan Huang; Hao Chen; Ning-Jia Zhou; Xue-Mei Zhang; Ji-Jun Chen
Journal:  Eur J Med Chem       Date:  2012-05-26       Impact factor: 6.514

Review 7.  Plant-derived lignans as potential antiviral agents: a systematic review.

Authors:  Xin-Ya Xu; Dong-Ying Wang; Yi-Ping Li; Stephen T Deyrup; Hong-Jie Zhang
Journal:  Phytochem Rev       Date:  2021-05-31       Impact factor: 7.741

8.  Hepatoprotective and antiviral efficacy of Acacia mellifera leaves fractions against hepatitis B virus.

Authors:  Ahmed H Arbab; Mohammad K Parvez; Mohammed S Al-Dosari; Adnan J Al-Rehaily; Mohammed Al-Sohaibani; Elwaleed E Zaroug; Mansour S AlSaid; Syed Rafatullah
Journal:  Biomed Res Int       Date:  2015-04-09       Impact factor: 3.411

Review 9.  Anti-HBV Drugs: Progress, Unmet Needs, and New Hope.

Authors:  Lei Kang; Jiaqian Pan; Jiaofen Wu; Jiali Hu; Qian Sun; Jing Tang
Journal:  Viruses       Date:  2015-09-15       Impact factor: 5.048

10.  In vitro evaluation of novel antiviral activities of 60 medicinal plants extracts against hepatitis B virus.

Authors:  Ahmed Hassan Arbab; Mohammad Khalid Parvez; Mohammed Salem Al-Dosari; Adnan Jathlan Al-Rehaily
Journal:  Exp Ther Med       Date:  2017-05-31       Impact factor: 2.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.